Point of Care Diagnostics Market Size and Share 2034
What is Driving the Growth of the Point-of-Care (POC) Diagnostic Market?
The point-of-care (POC) diagnostic market has become one of the fastest-growing segments in healthcare, with rising demand for quick, reliable, and cost-effective testing solutions. In 2024, the global market was valued at USD 15.05 billion, and it is projected to reach USD 34.03 billion by 2034, expanding at a CAGR of 8.50%. This growth is being fueled by the increasing focus on early detection, chronic disease monitoring, and the need for accessible testing in hospitals, diagnostic centers, and even at home.
Point-of-Care (POC) Diagnostic Market Size and Outlook
The market is gaining traction due to its role in reducing turnaround times and supporting timely medical decisions. Factors such as the rising prevalence of diabetes, cardiovascular diseases, infectious diseases, and cancer have heightened the need for rapid testing kits. In addition, healthcare systems worldwide are prioritizing decentralized testing to relieve pressure on hospitals and laboratories.
The increasing use of OTC testing kits and the expansion of molecular diagnostic platforms are also reshaping the market outlook, making POC diagnostics a cornerstone of modern preventive healthcare.
Point-of-Care (POC) Diagnostic Market Trends
Growing preference for self-testing kits in home healthcare
Advancements in molecular diagnostics and microfluidics for precision testing
Increased government funding for infectious disease management (HIV, COVID-19, TB, malaria)
Rising adoption of mobile health (mHealth) technologies integrated with POC devices
Expansion of cancer biomarker testing devices for early detection
These trends reflect a shift toward convenience, accuracy, and accessibility in diagnostics, making POC devices vital for both developed and emerging markets.
Drivers of Growth in the Point-of-Care (POC) Diagnostic Market
Rising chronic disease burden: Growing cases of diabetes, cardiovascular diseases, and respiratory conditions are driving higher adoption of glucose monitoring and cardiometabolic kits.
Pandemic preparedness: COVID-19 demonstrated the importance of rapid POC testing, accelerating innovation in infectious disease diagnostics.
Aging population: Elderly populations demand continuous monitoring for chronic diseases, spurring demand for easy-to-use diagnostic devices.
Technological integration: Microfluidics, AI, and smartphone connectivity are improving device accuracy and data management.
Shift to home-based care: Growing demand for at-home testing kits to reduce hospital visits and costs.
Technological Advancements in Point-of-Care (POC) Diagnostics
POC diagnostics are no longer limited to basic dipstick tests. Innovations include:
Molecular diagnostics for rapid genetic and infectious disease testing
Immunoassays with higher sensitivity and specificity
Microfluidics platforms allowing lab-on-a-chip testing
Connected devices that integrate with apps and cloud platforms for remote monitoring
These advancements are enhancing clinical decision-making, improving patient compliance, and opening new revenue streams for manufacturers.
Point-of-Care (POC) Diagnostic Market Trends You Can’t Afford to Miss!
Analyse market shifts, regulatory impacts, and emerging hotspots—grab your free report today!
Challenges and Opportunities
The POC diagnostic market faces challenges such as regulatory hurdles, data accuracy concerns, and high costs for advanced platforms. However, opportunities outweigh these barriers:
Expanding emerging markets in Asia Pacific and Latin America, where healthcare infrastructure is improving
Government programs supporting decentralized diagnostics in rural and underserved areas
R&D collaborations between diagnostics companies and digital health startups
Market Segmentation Analysis
By Product
Glucose Monitoring Kits: Largest segment due to rising diabetes cases globally
Infectious Diseases Testing Kits: High demand, particularly for HIV, malaria, and respiratory infections
Pregnancy and Fertility Testing Kits: Growing adoption in home-based self-testing
Haematology Testing Kits & Cardiometabolic Monitoring Kits: Increasing use in chronic disease monitoring
Tumour or Cancer Markers Testing Devices: Fastest-growing category as oncology shifts toward early detection
Drugs of Abuse and Faecal Occult Testing Kits: Gaining traction in forensic and preventive diagnostics
By Platform
Lateral Flow Assays: Widely used in infectious disease testing, pregnancy kits, and rapid COVID-19 tests
Dipsticks: Cost-effective but declining due to advanced alternatives
Microfluidics & Molecular Diagnostics: Fastest-growing due to accuracy and integration with digital technologies
Immunoassays: Strong adoption in professional diagnostic centers
By Mode of Purchase
Prescription-Based Products: Dominant in hospitals and critical care
OTC Products: Expanding rapidly, driven by self-testing demand
By End User
Hospitals and Critical Care Centres: Largest revenue share due to emergency care needs
Professional Diagnostic Centres: Growing adoption of specialized kits
Assisted Living Healthcare Facilities: Increasing usage for elderly monitoring
Research Laboratories: Driving demand for advanced molecular testing platforms
By Region
North America: Leading market with high adoption of innovative technologies
Europe: Strong regulatory support and advanced healthcare systems
Asia Pacific: Fastest-growing, driven by large patient base and government support
Latin America & Middle East and Africa: Emerging adoption due to healthcare modernization
Competitive Landscape
The point-of-care (POC) diagnostic market is highly competitive with both multinational corporations and specialized players. Key companies include:
Abbott Point of Care Inc. – Strong portfolio in glucose monitoring and rapid infectious disease tests
F. Hoffmann-La Roche Ltd – Expanding presence in molecular diagnostics
Chembio Diagnostics, Inc. – Focused on infectious disease testing solutions
Johnson & Johnson Services, Inc. – Broad diagnostics presence through subsidiaries
Siemens AG – Leveraging innovation in molecular and immunoassay platforms
Becton, Dickinson and Company – Expanding presence in hospital diagnostic solutions
Danaher Corp – Active in high-tech diagnostics and laboratory automation
Strategic moves include acquisitions, partnerships with digital health firms, and product launches targeting both professional and consumer segments.
FAQs
1. What is the current size of the point-of-care (POC) diagnostic market?
The global point-of-care (POC) diagnostic market was valued at USD 15.05 billion in 2024 and is expected to reach USD 34.03 billion by 2034, growing at a CAGR of 8.50%.
2. What factors are driving the point-of-care (POC) diagnostic market growth?
Key growth drivers include the rising prevalence of chronic diseases, demand for rapid infectious disease testing, technological advancements in molecular and microfluidics platforms, and the growing trend of home-based testing.
3. Which product segment dominates the market?
Glucose monitoring kits hold the largest share due to the increasing global diabetes burden, while cancer marker testing devices are projected to witness the fastest growth.
4. Which region is expected to show the highest growth?
Asia Pacific is anticipated to register the highest growth due to a large patient pool, rising healthcare expenditure, and strong government initiatives to improve diagnostic access.
5. Who are the leading players in the POC diagnostic market?
Major players include Abbott Point of Care Inc., F. Hoffmann-La Roche Ltd, Chembio Diagnostics, Johnson & Johnson Services, Siemens AG, Becton, Dickinson and Company, and Danaher Corp.
Uncover More Reports
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com